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Edited by Gerrit van MeerAbstract In this review, we summarize the currently available
information on the membrane topology of some key members
of the human ABC protein subfamilies, and present the predicted
domain arrangements. In the lack of high-resolution structures
for eukaryotic ABC transporters this topology is based only on
prediction algorithms and biochemical data for the location of
various segments of the polypeptide chain, relative to the mem-
brane. We suggest that topology models generated by the avail-
able prediction methods should only be used as guidelines to
provide a basis of experimental strategies for the elucidation of
the membrane topology.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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At present there are no high-resolution structural data avail-
able of any eukaryotic ABC transporter. Therefore, laborious
biochemical experiments are necessary to elucidate their mem-
brane topology, i.e., the position and orientation of membrane
spanning segments within the polypeptide chain. These meth-
ods include epitope insertion, localization of glycosylation
sites, limited proteolysis and immunochemical techniques. It
is worth to note that expression of truncated or non-functional
ABC proteins, or proteins expressed in heterologous expres-
sion system (e.g., mammalian ABC proteins in bacteria), as
well as fusion proteins can yield protein with aberrant mem-
brane topology.
It is generally accepted that the minimum structural require-
ment for a functional ABC transporter is the presence of two
transmembrane domains (TMD) and two ATP-binding cas-
sette (ABC or NBD) units. In humans these may be present
within one polypeptide chain (‘‘full transporters’’), or within
a membrane-bound homo- or heterodimer of ‘‘half-transport-
ers’’. The membrane topology models deﬁne the domain
arrangements for these variable ABC transporters.*Corresponding author. Fax: +361 466 5465.
E-mail address: varadi@enzim.hu (A. Va´radi).
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doi:10.1016/j.febslet.2005.11.040Several computer-assisted empirical prediction methods are
available to generate the hydrophobicity proﬁles and other se-
quence-based proﬁles for a putative transmembrane protein.
However, such analyses should be regarded only as ‘‘educated
guesses’’, serving as good starting points for an experimental
elucidation of the membrane topology.
Another experimental strategy is to predict the three-dimen-
sional structure of a eukaryotic ABC transporter by homology
modeling, based on the available crystal structure of a pro-
karyotic ABC transporter. In principle this is a valid approach,
as by now four high-resolution prokaryotic ABC-transport
structures are available [1–4], which are discussed in detail in
another review of this issue. Indeed, such homology models
have been constructed in the case of human Pgp1/MDR1/
ABCB1 [5] and for the membrane-embedded core (6 + 6 trans-
membrane helices) domain of human MRP1/ABCC1 [6].
These are again presented in other reviews of this special issue.
In our group we are currently establishing a database col-
lecting published information on the experimental data rele-
vant to the membrane topology of various families of
membrane proteins (Tusna´dy and Simon, unpublished). Such
data are sometimes generated with the aim of systematically
establishing the membrane topology of a given membrane pro-
tein, but the database also contains experimental ﬁndings
which per se hold information for the location of a given seg-
ment of the polypeptide chain relative to the membrane. These
include, e.g., cysteins involved in disulﬁde-bridge formation in
native state, which are usually not localized in the cytosol, or
peptide motifs interacting with intracellular proteins, indicat-
ing that this motif should be intracellular as well. We have
developed a membrane topology prediction approach which
is able to utilize the experimental data deposited in the above
database as constrains. A recent paper also argues for improv-
ing topology predictions by using experimental data [7].
In the present review, we apply our topology prediction
strategy (based on incorporation of experimental data into
the prediction algorithm) to provide information to the
most plausible membrane arrangements for the human ABC
transporters.2. Methodology
We used the Human ABC Proteins Database (http://nutri-
gene.4t.com/humanabc.htm) for the subfamily classiﬁcation.
We included only those members of a given subfamily into
the analysis whose full sequence were know. We choose theblished by Elsevier B.V. All rights reserved.
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alternatively spliced cDNAs were described. We omitted the
four ABC-proteins belonging to the ABCE and ABCF sub-
families, as these proteins contain no transmembrane domains.
Protein sequences with each subfamilies were aligned by
the ClustalW server (http://www.ebi.ac.uk/clustalw) [8]. The
ABCB half-transporters and full transporters were aligned
separately.
For computer-assisted prediction the HMMTOP (hidden
Markov model for topology prediction) transmembrane topol-
ogy prediction server has been utilized [9,10] (http://www.
enzim.hu/hmmtop). This method is based on the principle that
topology of transmembrane proteins is determined by the max-
imal divergence of amino acid composition of local sequence
segments. A special feature of this method that it can handle
experimentally observed topology information and provides
the most probable topology given these topology data as con-
strains. As an ‘‘initial condition’’, the intracellular locations of
the ABC-domains (deﬁned by the Walker A and Walker B
motifs in the linear sequence) were preset.
The results of the above analyses are presented as linear
block diagrams of the aligned sequences within a given sub-ABCA
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3.1. The ABCA-subfamily
The Human ATP-Binding Cassette Transporters Database
lists 12 members of the ABCA-subfamily, these are full trans-
porters with plasma membrane localization, and it is notewor-
thy that these proteins are the largest by the linear sequence
within the entire human ABC-protein family.
The membrane topologies of two members of the subfamily
were studied in detail. These are ABCA1, in which mutations
are responsible for the Tangier disease, and ABCA4, the ret-
ina-speciﬁc ABC transporter whose mutations cause several
retinopathies. The two proteins share 50% identical amino
acids.A1
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large extracellular domains (ECDs) between the ﬁrst and sec-
ond transmembrane helices of each predicted TMDs. An ele-
gant experimental proof of the Illing model has been
published [12]. Eight N-glycosylation sites were mapped by
mutagenesis within the bovine ABCA4 sequence, four within
the N-terminal half and four within the C-terminal half. These
results predicted an at least 400 amino acid extracellular do-
main within the N-terminal half, and a 200 amino acid extra-
cellular domain within the C-terminal half of the protein.
These authors also presented experimental data suggesting
that the two extracellular domains are linked with disulﬁde
bridge(s).
Fitzgerald et al. [13] expressed various truncated and tagged
versions of human ABCA1 and demonstrated that the large
loop between amino acids 44 and 640 indeed has an extracel-
lular orientation. Tanaka et al. [14] obtained the same results,
and they predicted a large extracellular loop within the C-ter-
minal half of the protein (between amino acids 1368 and 1655)
as well.
The experimental data obtained by the investigation of
ABCA1 and ABCA4 unequivocally support a similar mem-
brane topology for the two proteins with a domain arrangement
of TMH1-ECD1-TMH2-6-ABC1-TMH7-ECD2-TMH8-12-
ABC2. On the basis of these data similar domain arrangements
and membrane topologies can be predicted for the other mem-
bers of the ABCA-subfamily as well. Our sequence alignment
and topology prediction (Fig. 1) supports this assumption.
Tanaka et al. [14] ﬁrst described that a (presumably extracel-
lular) segment between residues 195 and 352 of ABCA7 and a
Sjogren syndrome autoantigen are identical, thus this part of
the ABCA7 protein serves as an epitope for the autoimmune
response found in this disease.
It is worth while to note that the ABCA family members can
be grouped on the basis of the length of their amino acid se-
quences. The ‘‘short’’ ABCA members (A3, A5, A6, A8, A9
and A10) contain approximately 1600 amino aids, and – with
the exception of A3 – they are located in the same chromo-
somal cluster (ch17.q24) and probably arose by gene multipli-
cation events during early vertebrate evolution. The ‘‘long’’
members (A1, A4, and A7) are built from 2100 to 2500 amino
acids.
As we mentioned above, all ABCA proteins are predicted to
have large extracellular loops between the ﬁrst and second TM
helices in both TM domains. The size diﬀerence between the
two groups is mostly due to the diﬀerent lengths of the ﬁrst
extracellular loop (ECD1) (Fig. 1). However, ABCA12 and
ABCA13 contain a domain in this region that is extremely
large: it is over 3500 amino acids in the case of ABCA13 (note
that we deleted some 2500 amino acids from this extracellular
loop of ABCA13 in Fig. 1). The ABCA13 protein is predicted
to contain 5058 amino acids and this is the largest known
ABC protein, and is among the largest mammalian proteins
[15].3.2. The ABCB-subfamily
Members of this subfamily are full transporters, including
ABCB1 (MDR1) or Pgp1, ABCB4 (MDR3) and ABCB11
(sisterPgp or BSEP), or half-transporters, like ABCB2 and
ABCB3 (TAP1 and TAP2). Similar half-transporters are the
mitochondrial transporters ABCB6, ABCB7, ABCB8 andABCB10, as well as ABCB9, with a putative lysosomal locali-
zation. The full transporters of the subfamily are localized in
the plasma membrane (in the apical membrane compartment),
while the half-transporters are found in the membranes of var-
ious organelles. It is well established that ABCB2/TAP1 and
ABCB3/TAP2 form a heterodimer, which actively translocates
peptides into the endoplasmic reticulum. The half- and the full
transporters of this subfamily are plotted separately in Fig. 1.
The membrane topology of ABCB1 has been elucidated by
epitope insertion experiments [16,17], as well as by introduc-
tion of pairs of cysteines into the predicted TM segments of
a Cys-less ABCB1, and by oxidative cross-linking [5,18], fully
supporting the original topology model of six TM helices in
both TMDs of the protein [19]. Sequence alignment reveals
that the half-transporters of the family are more closely related
to the C-terminal halves of the full transporters than to the N-
terminal halves. The topology predictions of the half-trans-
porters support the six TM helix model in their TMDs,
although their N-terminal regions contain additional, rela-
tively long sequences. Indeed, in the case of TAP1 and
TAP2, additional four and three TM helices were predicted,
respectively [20]. In other studies [21] eight (TAP1) and seven
(TAP2) TM helices were suggested. Eight TM helices were
identiﬁed in TAP1 by expressing fusion TAP1-b-galactosidase
polypeptides in Escherichia coli [22].
Interestingly, it was found recently that the minimal func-
tional unit of the transporter, which is essential and suﬃcient
for heterodimer assembly, peptide binding, and peptide trans-
location, is a 6 + 6 TM core-TAP1/TAP2 complex in which the
N-terminal additional helices are removed [23,24].
ABCB5 represents an ABC transporter with an unusual
structure: apparently it seems to be a close homolog of ABCB1
and ABCB4 (54% and 56% amino acid identity, respectively).
Interestingly, the protein lacks the ﬁrst transmembrane do-
main (TMD1) and a large portion of the ABC1 domain. This
would determine a ABCB-type half-transporter with a rather
unusual structure. In the ﬁrst publication describing the
ABCB5 protein a predicted membrane topology of ﬁve trans-
membrane helices ﬂanked by both extracellular and intracellu-
lar ATP-binding domains was published [25]. This
arrangement is not supported by our analysis (see Fig. 1),
which predicts the existence of a canonical, MDR1/ABCB1-
like six-helix TM domain in ABCB5. The high level of se-
quence identity between ABCB5 and ABCB1 or ABCB4 also
argues for similar transmembrane domains in these proteins.3.3. The ABCC-subfamily
The ABCC subfamily consists of 12 full transporters and
most of these (ABCC1-6 and ABCC10-11 or MRP1-6 and
MRP7-8) are identiﬁed as active membrane transporters of
various organic anions and hydrophobic drugs. The cystic
ﬁbrosis transmembrane conductance regulator, ABCC7
(CFTR) is a chloride channel that may also regulate other
channel proteins. The sulfonylurea receptors, ABCC8
(SUR1) and ABCC9 (SUR2), are intracellular ATP/ADP sen-
sors, regulating the permeability of speciﬁc K-channels (Kir
6.2 and Kir 6.1, respectively). The sulfonylurea receptors form
hetero-octameric transmembrane complexes with their K+
channel counterparts (building up from four SUR and four
K-channel polypeptides). Nothing is known about the function
ABCC12/MRP9 at present.
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fell into two diﬀerent subclasses (‘‘short and long’’), deter-
mined on the basis of their domain arrangement and mem-
brane topology.
The membrane topology of human CFTR/ABCC7 has been
established experimentally by glycosylation site insertion
mutagenesis [26], and this study revealed a TMD1-ABC1-R-
TMD2-ABC2 domain arrangement. Each TMD consist of
six TM helices, and a regulatory domain (R), the presence of
which is a unique feature of CFTRs, is present between the
two halves of the protein.
The membrane topology models for human ABCC1/MRP1
have been forwarded independently by two research groups
[27,28]. It was found that when the CFTR/ABCC7 and
MRP1/ABCC1 sequences were aligned, the hydrophobicity
analysis of the aligned sequences yielded a close matching of
the transmembrane segments, thus suggesting a 6 + 6 trans-
membrane helix topology for MRP1/ABCC1 as well. How-
ever, ABCC1 contains an N-terminal ‘‘extension’’ of about
230 amino acids, which had no counterpart in CFTR/ABCC7.
On the basis of the hydropathy proﬁles and limited proteolysis
experiments, the highly hydrophobic amino-terminal segment
of ABCC1 was suggested to be membrane embedded with ﬁve
transmembrane helices, with an extracellular amino-terminal.
Subsequent systematic investigations of the membrane
topology of human ABCC1 by epitope insertion [29,30] and
by mutation of glycosylation sites [31] fully supported the
above topology. These results indicate a domain arrangement
of TMD0-L0-TMD1-ABC1-L-TMD2-ABC2; in which TMD0
represents the N-terminal ﬁve TM helix extension, while L0
and L represents intracellular linker sequences. By aligning
the linear sequences and the hydrophobicity plots of all full-
size ABC transporters present in the sequence database in
1996 it was concluded that ABCC proteins with the above
membrane topology and domain arrangement can be found
within the eukaryotic ABC-kingdom [32]. The 17 transmem-
brane helices topology (i.e., the TMD0-L0-TMD1-ABC1-L-
TMD2-ABC2 domain arrangement) of SUR1/ABCC8 has
been proven experimentally as well [33].
The amino acid sequences of the long and those of the short
members of the ABCC subfamily were aligned and the mem-
brane topology plots of the aligned protein sequences were cal-
culated (Fig. 1). This comparison indicates that seven proteins
of the family (i.e., ABCC1-3, ABCC6, and ABCC8-10) form a
subcluster within which each member possesses the N-terminal
TMD0 domain ﬁrst described for ABCC1. Thus this subgroup
is characterized by the TMD0-L0-TMD1-ABC1-L-TMD2-
ABC2 arrangement. The N-terminal TMD0 domain is absent
from ABCC4, ABCC5, from CFTR/ABCC7, from ABCC11
and from ABCC12. The two subclusters are plotted separately
in Fig. 1. Interestingly, the segregation by size, i.e., whether the
N-terminal TM (TMD0) is present or not in the ABCC-type
protein does not correlate with the degree of sequence similar-
ity, nor with function, i.e., whether the given ABCC family
member acts as an active transporter or as a channel/channel
regulator.
The presence of a TMD0-like domain in the long ABCC
transporter is unique, and its general function (if any) remains
to be clearly established. The TMD0 of ABCC1 does not play
a crucial role either in transport activity of the protein, or its
proper routing into the basolateral membrane compartment,
while the presence of the L0 (together with the TMD1-ABC1-L-TMD2-ABC2 core) is necessary for ABCC1-like
transport activity and for the proper intracellular routing of
the protein [34]. The ABCC1 L0 polypeptide was found to
be membrane associated, and a 10 amino acids deletion of this
region, containing a putative amphipatic helix abolished the
L0 – membrane interaction and eliminated transport function,
while did not harm membrane routing [35]. The conclusion of
these studies is that the L0 region forms a distinct structural
and functional domain, which interacts with the membrane
and with the core region of the transporter. The amino-termi-
nal cytoplasmic tail of CFTR/ABCC7 (which corresponds to
the L0 domain) was found to control channel gating via a
physical interaction with the regulatory (R) domain [36], while
the L0 domain of SUR1 (together with the TMD0) modulate
gating of the K-channel [37].
Recent studies revealed that recycling of the full length and
the TMD0- deleted ABCC1 is diﬀerent: while only a small por-
tion of wt ABCC1 is found in the recycling endosome, approx.
half of the TMD0-deleted ABCC1 were present in this cellular
compartment. This means that the N-terminal membrane-
bound region (TMD0) of ABCC1 plays a role in the internal-
ization of ABCC1 [38]. A well-characterized function can be
attributed to the TMD0 region of ABCC8/SUR1: it was shown
that it is essential for the assembly of the SUR1 + Kir 6.2 com-
plex and then exit the ER [39].
The eﬀorts of generating antibodies recognizing extracellular
epitope(s) in ABCC1 and in other ABCC-like pumps were
unsuccessful indicating that the extracellular loops and the
extracellular amino-terminal segment of the ‘‘long-ABCCs’’
are relatively short and/or buried. However, recently, using a
phage display approach, a recombinant single-chain Fv (scFv)
antibody that speciﬁcally recognizes the extracellular N-termi-
nal tail of the human ABCC1 has been developed [40].3.4. The ABCD-subfamily
Four half-transporters with TMD-ABC arrangement,
ABCD1/ALDP, ABCD2/ALDR, ABCD3/PMP70, and
ABCD4/PMP70R, are members of this family; they are local-
ized to the peroxisomal membrane and their mutant forms are
involved in diﬀerent inherited peroxysomal disorders. It has
been proposed that peroxysomal transporters need to dimerize
to exert their function. Co-immunoprecipitation experiments
demonstrated the homodimerization of ABCD1, the hetero-
dimerization of ABCD1 with ABCD3 or ABCD2, and the het-
ero-dimerization of ABCD2 with ABCD3 [41].
The presence of six TM helices in the TMDs of the ABCD-
halftransporters is generally predicted, but the experimental
veriﬁcation of the prediction is still ahead. Using adrenoleuko-
dystrophy protein ABCD1 deletion constructs it was estab-
lished that the amino acid regions 1–110 and 67–164 are
suﬃcient for peroxisomal targeting [42].3.5. The ABCG-subfamily
The members of this subfamily are half-transporters with a
unique domain arrangement of ABC-TMD. Five proteins of
this subgroup with full sequences are known. The best charac-
terized transporter is ABCG2, whose overexpression confers
multidrug resistance. There is genetic as well as biochemical
evidence that ABCG5 and ABCG8 form heterodimers as it
was found that mutations of either genes cause a rare recessive
genetic disease, sitosterolemia [43,44] and the interaction of the
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overexpression of the ABCG2 multidrug resistance protein in
insect cells was found to generate an active ATPase, strongly
suggesting that this protein can act as a homodimer [46]. Inter-
estingly, these proteins (i.e., ABCG2, ABCG5 and ABCG8)
are N-glycosylated in their matured form, which suggests that
they are localized in the plasma membrane, while other half
ABC transporters of the ABCB and ABCD subfamilies are
localized in the membranes of various intracellular organelles.
No experimental data are available as of today on the exact
membrane topology of the ABCG-transporters. ABCG2 car-
ries three putative N-glycosylation sites at positions 418, 557,
and 596. Site-directed mutagenesis experiments, in which each
Asn was changed to Gln independently, revealed that only
asparagine 596 is N-glycosylated [47].
The involvement of three Cys residues of human ABCG2 in
disulﬁde-bridge formation has been described in a recent pub-
lication [48]. It was found that Cys603 forms a symmetrical
interchain disulﬁde-bridge between two ABCG2 half-trans-
porters, while Cys592 and Cys 608 are involved in intrachain
disulﬁde-bridge formation.
Collectively, these observations suggest that in ABCG2 seg-
ment 592–608 is extracellular. According to the prediction
illustrated in Fig. 1, the above segment is part of the third
extracellular loop of ABCG2.
The N-glycosylation sites of the mouse ABCG5 and ABCG8
have been determined [49], it has been shown that Asn 585 and
Asn 592 in ABCG5 and Asn 619 in ABCG8 carry the N-linked
glycan chains. As asparagines are preserved in the human
transporters at the same positions (584 and 591 in human
ABCG5 and 619 in human ABCG8), it is rather safe to predict
that the human proteins are also glycosylated in these posi-
tions. These data indicate that, in accordance with the predic-
tions, the 584–591 region of ABCG5 and position 619 in
ABCG8 are extracellular.4. Concluding remarks
The key feature of the strategy we have used here to predict
the membrane topology of human ABC transporters was that
relevant experimental data could have been used as input by
the computer-assisted prediction software applied. Unfortu-
nately, the majority of the prediction algorithms cannot handle
the results of wet lab experiments, such data cannot be used as
constrains of the prediction. By using the publicly available
prediction method, which is unique, as it accepts such inputs,
we were able to construct coherent homology models for each
subfamily, except for the ABCD family members, as in this lat-
ter case there are no available experimental topology data.
The homology models indicate most of the (predicted) extra-
cellular regions of the ABC proteins are short. In contrast,
members of the ABCA family possess of two large, sometimes
extremely large, extracellular loops. Also, the C-proximal
extracellular loop in the ABCG subfamily is a relatively long
segment. In general, a typical pattern of six TM helices is pre-
served in the core transmembrane domains of all ABC half-
transporters and this core structure is duplicated in the full
transporters. Additional N-terminal regions may have impor-
tant functions in the ABCC family members and in the ABCB
half-transporters.Acknowledgments: This work has been supported by the following
grants: OTKA T049073, AT048729, D42207, and NKFP MediChem2.
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